ARCHIVES

HIPAA Interpretations Vary, Delay Research, ASCO Study Finds

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

NEJM Sanctioned For Giving CME Credit For Controversial Lung Screening Paper; ACCME Demanded Corrective Action

January 9, 2009

DCBD Board Okays Recompetition Of Human Tissue Network

June 30, 1989

In Brief: Phillip Sharp Selected Next MIT President; Montgomery Retires From SRI Administration

February 23, 1990

Litton Wins FCRF Research Contract, Harland Land Animal Protections

September 17, 1982

NCAB Approves Plan for Public Participation Hearings Around U.S.

February 20, 1987